Eirion Therapeutics Reports First-in-Human ET-02 Data
Woburn, Massachusetts, USA, September 17, 2026 Eirion Therapeutics, Inc. announced that it will present first-in-human clinical data for ET-02,...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Woburn, Massachusetts, USA, September 17, 2026 Eirion Therapeutics, Inc. announced that it will present first-in-human clinical data for ET-02,...
Sacramento, California, U.S., September 16, 2026 Lunai Bioworks, Inc. has announced results from a technical case study demonstrating an...
Miami, Florida, USA, September 16, 2026 Synergy Spine Solutions® has highlighted new two-year clinical outcomes for its FDA-approved Synergy...
Geneva, Switzerland , Aug 26, 2026 Spineart and eCential Robotics have announced that the U.S. Food and Drug Administration...
BOCA RATON, Fla., June 2026 SurGenTec® has announced U.S. FDA clearance for its ION-L™ Lumbar Facet Fixation System, a...
